520 results
Page 3 of 26
425
hu1eav
6 Jul 22
Business combination disclosure
4:05pm
425
pgzfdr1hioz0w svg6c
9 Jun 22
Business combination disclosure
4:01pm
8-K
EX-99.2
8wxu309tc99kh7sw35
23 May 22
Caladrius Biosciences Provides Update on Phase 2b FREEDOM Trial of XOWNA® in Coronary Microvascular Dysfunction
4:08pm
8-K
EX-99.1
09sq sfs9c9bubc77v
23 May 22
Caladrius Biosciences Provides Update on Phase 2b FREEDOM Trial of XOWNA® in Coronary Microvascular Dysfunction
4:08pm
8-K
EX-99.2
n6lnk8008onmewglu
5 May 22
Caladrius Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
8-K
EX-99.1
71f5xu39nl4ygi lgz
5 May 22
Caladrius Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
8-K
EX-2.2
y8egs11nbem
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
61rh8dt xbn097jcxj2
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-99.2
6jlmmn3xy
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-99.1
pi8l8xz
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-2.3
ra0jxkoy1qp1y7j38
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-2.1
k6vyw
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-99.2
33g628bt hp9s7rs
22 Mar 22
Caladrius Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:09pm
8-K
EX-99.1
4mbhiy
22 Mar 22
Caladrius Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:09pm
8-K
EX-99.2
9xt3tpg34aox4 c4f
4 Nov 21
Caladrius Biosciences Provides Corporate Update and Reports 2021 Third Quarter Financial Results
4:09pm